(+)-Tetrabenazine

Research use only, not for human use.

(+)-Tetrabenazine ((3R,11bR)-Tetrabenazine) is a reversible vesicular monoamine transporter 2 (VMAT-2) inhibitor, inhibits transport by VMAT2 with 10-fold greater potency than transport by VMAT1.

(+)-Tetrabenazine ((+)-TBZ; (3R,11bR)-TBZ; (3R,11bR)-Tetrabenazine) is a reversible inhibitor of vesicular monoamine transporter 2 (VMAT-2),inhibits transport by VMAT2 with 10-fold greater potency than transport by VMAT1. target: VMAT-2In vitro: (+)-Tetrabenazine inhibit the activity of the transporter but appear to interact differently with the protein. (+)-Tetrabenazine inhibits reserpine binding to the transporter, suggesting that the sites may interact in an allosteric manner. In vivo:0.9% saline (80%) and dimethylsulfoxide (DMSO) (20%). (+)-Tetrabenazine blocks dopamine (DA) storage and depletes striatal DA; (+)-Tetrabenazine was shown to induce tremulous jaw movements (TJMs) in rats and mice. The reference dose for administration is 2.0 mg/kg.

——

——

——

Membrane Transporter/Ion Channel

Monoamine Transporter

Monoamine Transporter

——

——

1026016-83-0

317.42

C19H27NO3

>98% (HPLC)

In Vitro:?DMSO : 16.67 mg/mL (52.52 mM; Ultrasonic )

[H][C@]12CC(=O)[C@H](CC(C)C)CN1CCc1cc(OC)c(OC)cc21

——

(-20℃)

With Ice Pack

≥ 2 years